Halozyme Therapeutics, Inc. (LON: 0J2O)
London
· Delayed Price · Currency is GBP · Price in USD 55.23
-0.23 (-0.41%)
Jan 22, 2025, 7:13 PM BST
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of 5.71 billion as of January 23, 2025. Its market cap has increased by 50.18% in one year.
Market Cap
5.71B
Enterprise Value
6.42B
Revenue
706.82M
Ranking
n/a
PE Ratio
19.50
Stock Price
55.23
Market Cap Chart
Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 95.57M to 5.71B, an increase of 5,875.17%. That is a compound annual growth rate of 21.84%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |